Helix BioMedix, Inc. (HXBM)

1.79 0.00 (0.00%) USD  |  OTCM  |  Jun 26, 16:00
More

Helix BioMedix Cash and Short Term Investments (Quarterly)

Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for HXBM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
September 30, 2012 0.2165M
June 30, 2012 0.7391M
March 31, 2012 1.164M
December 31, 2011 1.689M
September 30, 2011 2.067M
June 30, 2011 2.660M
March 31, 2011 3.271M
December 31, 2010 4.044M
September 30, 2010 2.027M
June 30, 2010 3.036M
March 31, 2010 3.593M
December 31, 2009 1.345M
September 30, 2009 2.090M
June 30, 2009 2.807M
March 31, 2009 3.531M
December 31, 2008 1.955M
September 30, 2008 2.513M
June 30, 2008 2.425M
March 31, 2008 3.165M
December 31, 2007 1.161M
September 30, 2007 2.003M
June 30, 2007 2.744M
March 31, 2007 3.645M
December 31, 2006 2.257M
September 30, 2006 3.130M
Date Value
June 30, 2006 3.852M
March 31, 2006 4.705M
December 31, 2005 2.828M
September 30, 2005 3.523M
June 30, 2005 4.336M
March 31, 2005 3.764M
December 31, 2004 1.908M
September 30, 2004 2.536M
June 30, 2004 3.108M
March 31, 2004 2.402M
December 31, 2003 2.071M
September 30, 2003 1.527M
June 30, 2003 1.933M
March 31, 2003 1.748M
December 31, 2002 1.031M
September 30, 2002 0.4468M
June 30, 2002 0.6469M
March 31, 2002 0.8099M
December 31, 2001 0.401M
September 30, 2001 0.3241M
June 30, 2001 0.0527M
March 31, 2001 0.06M
December 31, 2000 0.4906M
September 30, 2000 0.7515M
June 30, 2000 0.9678M

Cash and Short Term Investments Definition

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 851.46M
Alnylam Pharmaceuticals, Inc. 3.009B
Anika Therapeutics, Inc. 41.02M
Savara, Inc. 202.77M
Vericel Corp. 145.34M